Skip to main content
. Author manuscript; available in PMC: 2015 Sep 3.
Published in final edited form as: J Cancer Surviv. 2012 Dec 5;7(1):93–103. doi: 10.1007/s11764-012-0248-4

Table 2.

Comorbidities reported by female respondents with or without previous breast cancer diagnoses, by race/ethnicity (percent)—BRFSS, 2009

Breast cancer survivors (median
age=68; n=10,035)
 Women without previous diagnoses of
breast cancer (median age=55; n=234,385)
White
(n=8,825)
%		 Black,
(n=631)
%		 Hispanic
(n=0280)
%		 Other
(n=299)
%		 White
(n=190,455)
%		 Black,
(n=20,628)
%		 Hispanic
(n=14,213)
%		 Other
(n=9,089)
%
Arthritisa,b
Yes 55.2 48.5 32.7 45.3 31.9 28.8 17.7 19.2
No 44.5 51.2 67.2 54.7 67.8 70.7 82.0 80.5
Unknown 0.2 0.2 0.1 0.0 0.3 0.5 0.2 0.3
Asthmab
Yes 13.5 20.5 9.5 10.4 15.2 16.8 13.4 14.6
No 86.3 79.2 90.4 89.6 84.6 83.0 86.5 85.2
Unknown 0.2 0.2 0.1 0.0 0.2 0.2 0.2 0.2
Cardiovascular diseasea,b
Yes 14.2 8.8 11.0 9.0 6.6 8.0 4.8 5.5
No 84.8 89.4 88.9 82.7 92.8 91.3 94.4 94.0
Unknown 1.0 1.8 0.1 8.3 0.6 0.8 0.8 0.5
Diabetesa,b
Yes 13.1 30.1 14.2 21.9 7.4 13.3 9.7 8.3
No 86.8 69.8 85.8 78.1 92.5 86.6 90.2 91.6
Unknown 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.1
Hypertensiona,b
Yes 45.2 71.1 35.3 41.2 27.6 39.9 20.7 21.4
No 54.6 28.9 64.5 58.2 72.2 60.0 79.2 78.4
Unknown 0.1 0.0 0.2 0.6 0.2 0.1 0.1 0.2
None of the abovea,b 22.9 13.8 41.1 24.6 53.6 59.0 40.8 41.3
Mean number of comorbiditiesc 1.42 1.79 1.03 1.28 0.89 1.07 0.67 0.69

White, Black and “Other” respondents are of non-Hispanic ethnicity. “Other” includes respondents who self-identified as Asian, Native Hawaiian, other Pacific Islander, American Indian, Alaska Native or other. Breast cancer survivors consist of all female respondents who reported a previous diagnosis of breast cancer. Values are expressed as weighted percentage to account for differences in demographic parameters and sampling bias and are representative of the USA population

BRFSS Behavioral Risk Factor Surveillance System

a

Pearson chi-square test for differences in the distribution of demographic and clinical characteristics across the four racial/ethnic groups was significant (p<0.01) among breast cancer survivors

b

Pearson chi-square test for differences in the distribution of demographic and clinical characteristics across the four racial/ethnic groups was significant (p<0.01) among non-breast cancer respondents

c

Analysis of variance p value testing for differences across the four racial/ethnic groups was significant (p<0.01)